Portal de Periódicos da CAPES

COVID-19 and anosmia: A review based on up-to-date knowledge

2020; Elsevier BV; Volume: 41; Issue: 5 Linguagem: Inglês

10.1016/j.amjoto.2020.102581

1532-818X

Xiangming Meng, Yanzhong Deng, Zhiyong Dai, Zhisheng Meng,

Long-Term Effects of COVID-19

The pandemic of Coronavirus Disease 2019 (COVID-19) has caused a vast disaster throughout the world. There is increasing evidence that olfactory dysfunction can present in COVID-19 patients. Anosmia can occur alone or can be accompanied by other symptoms of COVID-19, such as a dry cough. However, the pathogenic mechanism of olfactory dysfunction and its clinical characteristics in patients with COVID-19 remains unclear. Multiple cross-sectional studies have demonstrated that the incidence rate of olfactory dysfunction in COVID-19 patients varies from 33.9–68% with female dominance. Anosmia and dysgeusia are often comorbid in COVID-19 patients. Otolaryngologists should be mindful of the symptom of anosmia in outpatients so as not to delay the diagnosis of COVID-19. In this paper, we have reviewed the relevant knowledge based on up-to-date literature.